The Procter & Gamble Manufacturing Company
FDA inspection history in Browns Summit, North Carolina, 2017 to 2022
- 2
- Form 483s
Every document, by year
- Form 483
2017: one Form 483; 2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2017One Form 483, at Browns Summit, North Carolina.
- 2022One Form 483, at Browns Summit, North Carolina.
- 2022The longest 483 on file: 3 observations over 5 pages at Browns Summit, North Carolina.
Cited most
Across all The Procter & Gamble Manufacturing observations on file
- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products1
- 21 CFR 211.192Production record review1
- 21 CFR 211.194(a)(8)Laboratory records1
- 21 CFR 211.67(b)Equipment cleaning and maintenance1
The complete The Procter & Gamble Manufacturing file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Browns Summit, North Carolina
Two Form 483s · 2017 to 2022 · 4 observations
Latest: Form 483, Feb 18, 2022 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-02-18 | 483 Form 483 | Browns Summit, North Carolina | 3 | $99 |
| 2017-03-10 | 483 Form 483 | Browns Summit, North Carolina | 1 | $99 |
Investigators on these documents
FEI number 1033800 · most recent document Feb 18, 2022
About The Procter & Gamble Manufacturing Company
How many FDA Form 483s has The Procter & Gamble Manufacturing Company received?
FDA Intel has 2 Form 483s on file for The Procter & Gamble Manufacturing Company; the most recent is dated Feb 18, 2022.
When was The Procter & Gamble Manufacturing Company last inspected by FDA?
The most recent FDA inspection document on file for The Procter & Gamble Manufacturing Company is a Form 483 dated Feb 18, 2022, for the site in Browns Summit, North Carolina.
What did FDA cite at The Procter & Gamble Manufacturing Company?
The regulations cited most in the observations on file for The Procter & Gamble Manufacturing Company are 21 CFR 211.110(a) (Sampling and testing of in-process materials and drug products), 1 time; 21 CFR 211.192 (Production record review), 1 time; 21 CFR 211.194(a)(8) (Laboratory records), 1 time.